A leading international research and consulting firm predicts double-digit growth for surgical foot and ankle devices, according to April remarks by Linda Tian, MSc, an analyst for the company, London-based GlobalData.
Tian said an expanding patient pool with unmet needs in procedures such as ankle fusion, total ankle replacement (TAR), and other types of foot reconstruction will drive growth.
“In the past two years, the search for growth has led to an increase in merger and acquisition activities in the foot and ankle segment. Several new lines have now been brought to the market, including screws, plates, implants, and biomaterials,” said Tian, who expects this consolidation to draw interest from smaller merger and acquisition candidates in the surgical foot and ankle devices market.
GlobalData named TAR, an option for some patients with late-stage ankle arthritis, as the ankle procedure with the greatest growth potential, noting US surgeons did about 5000 TAR procedures in 2013. Tian noted this particular TAR market value is expected to increase at a compound annual growth rate (CAGR) of 16.9%, reaching $141.6 million by 2020.